The global Pharmacogenomics Technology Market was valued at USD 6.26 billion in 2023 and is projected to nearly double to USD 13.15 billion by 2032, growing at a robust compound annual growth rate (CAGR) of 8.64% from 2024 to 2032. This substantial expansion underscores the rising importance of personalized medicine and the vital role pharmacogenomics plays in shaping the future of healthcare....